Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
Laura C. Coates(Nuffield Orthopaedic Centre), Philip Helliwell(University of Leeds), Lucy McParland, John O’Dwyer(University of Leeds), Nuria Navarro-Coy(University of Leeds), Sarah Brown(University of Leeds), David Meads(University of Leeds), Paul Emery(University of Leeds), Philip G. Conaghan(University of Leeds), Anna R. Moverley(University of Leeds)
Cited by 477
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
|Annals of the Rheumatic Diseases|2011|988
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis
|Arthritis & Rheumatology|2016|904